Last 13 quarters of trend data · Industrials · Consulting Services
Quarterly valuation ratios — annualised for comparability. YoY Δ shows same-quarter-prior-year change.
SBC Medical Group Holdings Incorporated's quarterly P/E stands at 0.7x, up 207.8% year-over-year — indicating the stock has re-rated higher or earnings have softened.
| Metric | TTM | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| P/E Ratio → | 0.37 | 0.68 | 0.37 | 0.43 | 2.03 | 0.22 | 0.94 | 1.26 | — | — | — | — | — |
| — | +207.8% | -61.1% | -65.5% | — | — | — | — | — | — | — | — | — | |
| P/S Ratio | 0.11 | 0.18 | 0.13 | 0.12 | 0.12 | 0.10 | 0.14 | 0.07 | — | — | — | — | — |
| — | +76.0% | -4.0% | +83.8% | — | — | — | — | — | — | — | — | — | |
| P/B Ratio | 0.07 | 0.11 | 0.08 | 0.09 | 0.08 | 0.08 | 0.13 | 0.07 | — | — | — | — | — |
| — | +34.0% | -36.7% | +24.4% | — | — | — | — | — | — | — | — | — | |
| P/FCF | 0.53 | 0.89 | 0.08 | — | — | 4.09 | — | 0.09 | — | — | — | — | — |
| — | -78.4% | — | — | — | — | — | — | — | — | — | — | — | |
| EV / EBITDA | -1.32 | -1.58 | -1.68 | -1.17 | -1.93 | -0.99 | -3.90 | -1.60 | — | — | — | — | — |
| — | -58.7% | +56.9% | +26.7% | — | — | — | — | — | — | — | — | — | |
| EV / EBIT | -1.38 | -1.64 | -1.22 | -1.05 | -2.16 | -0.78 | -3.63 | -1.81 | — | — | — | — | — |
| — | -108.7% | +66.3% | +42.0% | — | — | — | — | — | — | — | — | — |
Quarterly margins and returns. Watch for margin compression across consecutive quarters.
SBC Medical Group Holdings Incorporated's operating margin was 41.2% in Q1 2026, up 8.7 pp QoQ and down 10.0 pp YoY. The trailing four-quarter average of 36.0% lags the current quarter, suggesting the recent improvement is above-trend. Gross margin contracted 12.5% YoY, suggesting cost inflation or competitive pricing pressure.
| Metric | TTM | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 73.3% | 69.8% | 73.1% | 70.6% | 69.2% | 79.7% | 76.3% | 81.5% | 74.2% | 72.1% | 69.6% | 70.9% | — |
| — | -12.5% | -4.1% | -13.3% | -6.8% | +10.6% | +9.6% | +15.0% | — | — | — | — | — | |
| Operating Margin | 38.9% | 41.2% | 32.5% | 36.6% | 33.6% | 51.1% | 10.6% | 26.1% | 51.4% | 44.6% | 38.5% | 42.4% | — |
| — | -19.5% | +205.7% | +40.6% | -34.7% | +14.6% | -72.4% | -38.5% | — | — | — | — | — | |
| Net Margin | 29.4% | 26.3% | 35.9% | 29.6% | 5.7% | 45.4% | 14.7% | 5.3% | 34.8% | 34.2% | 23.0% | 17.7% | — |
| — | -42.2% | +143.8% | +454.3% | -83.7% | +32.7% | -36.0% | -69.8% | — | — | — | — | — |
| Metric | TTM | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ROE | 22.2% | 4.2% | 5.6% | 5.2% | 1.0% | 10.2% | 3.3% | 2.6% | 165.5% | 24.2% | 18.1% | 55.6% | 0.3% |
| — | -58.5% | +70.1% | +98.9% | -99.4% | -57.8% | -81.9% | -95.3% | +54495.2% | +244367.7% | — | — | — | |
| ROA | 15.8% | 2.9% | 4.0% | 4.0% | 0.8% | 7.8% | 2.3% | 1.8% | 94.1% | 13.5% | 10.2% | 38.8% | 0.3% |
| — | -62.3% | +74.1% | +124.7% | -99.1% | -42.0% | -77.3% | -95.4% | +33540.5% | +140390.6% | — | — | — | |
| ROIC | 43.4% | 9.7% | 6.4% | 9.3% | 10.1% | 19.1% | 4.0% | 19.1% | 165.8% | 48.3% | 45.5% | 98.4% | -0.5% |
| — | -49.2% | +62.2% | -51.3% | -93.9% | -60.5% | -91.3% | -80.6% | +30309.4% | +24305.8% | — | — | — |
Quarterly solvency trend — watch for debt spikes or covenant pressure.
SBC Medical Group Holdings Incorporated's Debt/EBITDA ratio is 1.1x, down from 3.8x last quarter — comfortably within a safe range. The current ratio has weakened 14.0% YoY to 3.82x, tightening the short-term liquidity position.
| Metric | TTM | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debt / Equity | 0.20 | 0.08 | 0.20 | 0.11 | 0.06 | 0.06 | 0.06 | 0.14 | 0.25 | 0.24 | 0.16 | 0.07 | 0.07 |
| — | +21.4% | +213.1% | -17.5% | -74.1% | -73.9% | -60.6% | +106.0% | +269.6% | — | — | — | — | |
| Debt / EBITDA | 0.74 | 1.11 | 3.82 | 1.69 | 1.02 | 0.57 | 2.16 | 1.90 | 0.10 | 0.11 | 0.86 | 0.05 | 2.75 |
| — | +95.9% | +76.6% | -11.1% | +964.9% | +435.8% | +151.0% | +3911.7% | -96.5% | — | — | — | — | |
| Current Ratio | 3.78 | 3.82 | 3.78 | 5.10 | 3.98 | 4.44 | 3.01 | 2.79 | 0.32 | 0.40 | 1.79 | 0.30 | 0.46 |
| — | -14.0% | +25.5% | +82.6% | +1135.1% | +1003.8% | +68.0% | +817.6% | -30.6% | -87.6% | — | — | — | |
| Quick Ratio | 3.74 | 3.78 | 3.74 | 4.75 | 3.95 | 4.12 | 2.99 | 2.76 | 0.32 | 0.40 | 1.76 | 0.30 | 0.46 |
| — | -8.2% | +25.0% | +71.9% | +1126.4% | +923.8% | +69.8% | +808.6% | -30.6% | -87.6% | — | — | — | |
| Interest Coverage | 512.05 | 154.35 | 332.02 | 381.53 | 273.71 | 5068.09 | 489.60 | 2399.01 | 3649.50 | 9044.28 | 2979.40 | 5297.64 | — |
| — | — | — | — | — | — | — | — | — | — | — | — | — |
Includes 30+ ratios · 13 years · Updated daily
DCF models, multiple analysis, and analyst estimates.
10-year return with dividends reinvested.
See how regular investing compounds over time.
Compare growth, multiples, and margins vs sector.
Quick answers to the most common questions about buying SBCWW stock.
SBC Medical Group Holdings Incorporated's current P/E is 0.4x. The average P/E over the last 4 quarters is 0.9x. Quarterly P/E ratios can vary due to seasonal revenue patterns and one-time charges.
SBC Medical Group Holdings Incorporated's current operating margin is 38.9%. Margins have been expanding over recent quarters. Quarterly margins are particularly useful for identifying trend inflections that annual data smooths over.
Quarterly financial ratios reveal short-term trend shifts — margin compression, debt spikes, or valuation re-ratings — that annual figures smooth over. They're essential for active investors tracking SBC Medical Group Holdings Incorporated's business trajectory between earnings reports.